Literature DB >> 32417755

N- and C-terminal regions of αB-crystallin and Hsp27 mediate inhibition of amyloid nucleation, fibril binding, and fibril disaggregation.

Emily E Selig1,2, Courtney O Zlatic1,2, Dezerae Cox1,2, Yee-Foong Mok1,2, Paul R Gooley1,2, Heath Ecroyd3,4, Michael D W Griffin5,2.   

Abstract

Small heat-shock proteins (sHSPs) are ubiquitously expressed molecular chaperones that inhibit amyloid fibril formation; however, their mechanisms of action remain poorly understood. sHSPs comprise a conserved α-crystallin domain flanked by variable N- and C-terminal regions. To investigate the functional contributions of these three regions, we compared the chaperone activities of various constructs of human αB-crystallin (HSPB5) and heat-shock 27-kDa protein (Hsp27, HSPB1) during amyloid formation by α-synuclein and apolipoprotein C-II. Using an array of approaches, including thioflavin T fluorescence assays and sedimentation analysis, we found that the N-terminal region of Hsp27 and the terminal regions of αB-crystallin are important for delaying amyloid fibril nucleation and for disaggregating mature apolipoprotein C-II fibrils. We further show that the terminal regions are required for stable fibril binding by both sHSPs and for mediating lateral fibril-fibril association, which sequesters preformed fibrils into large aggregates and is believed to have a cytoprotective function. We conclude that although the isolated α-crystallin domain retains some chaperone activity against amyloid formation, the flanking domains contribute additional and important chaperone activities, both in delaying amyloid formation and in mediating interactions of sHSPs with amyloid aggregates. Both these chaperone activities have significant implications for the pathogenesis and progression of diseases associated with amyloid deposition, such as Parkinson's and Alzheimer's diseases.
© 2020 Selig et al.

Entities:  

Keywords:  Hsp27; alpha-synuclein (α-synuclein); amyloid; apolipoprotein C-II; chaperone; neurodegenerative disease; protein misfolding; small heat shock protein (sHsp); structure–function; αB-crystallin

Mesh:

Substances:

Year:  2020        PMID: 32417755      PMCID: PMC7380184          DOI: 10.1074/jbc.RA120.012748

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  The small heat shock protein alphaB-crystallin inhibits differentiation-induced caspase 3 activation and myogenic differentiation.

Authors:  Ryuji Ikeda; Kenichi Yoshida; Mina Ushiyama; Tatsuya Yamaguchi; Ken-ichi Iwashita; Toshitaka Futagawa; Yoshihiko Shibayama; Shigeru Oiso; Yasuo Takeda; Hiroko Kariyazono; Tatsuhiko Furukawa; Kazuo Nakamura; Shin-ichi Akiyama; Ituro Inoue; Katsushi Yamada
Journal:  Biol Pharm Bull       Date:  2006-09       Impact factor: 2.233

2.  The taming of small heat-shock proteins: crystallization of the alpha-crystallin domain from human Hsp27.

Authors:  E V Baranova; S Beelen; N B Gusev; S V Strelkov
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-11-27

3.  Crystal structure of a small heat-shock protein.

Authors:  K K Kim; R Kim; S H Kim
Journal:  Nature       Date:  1998-08-06       Impact factor: 49.962

4.  Small heat shock protein 27 (HSP27) associates with tubulin/microtubules in HeLa cells.

Authors:  M Hino; K Kurogi; M A Okubo; M Murata-Hori; H Hosoya
Journal:  Biochem Biophys Res Commun       Date:  2000-04-29       Impact factor: 3.575

5.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

Authors:  M G Spillantini; R A Crowther; R Jakes; M Hasegawa; M Goedert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes.

Authors:  W S Davidson; A Jonas; D F Clayton; J M George
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

7.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

Authors:  M Baba; S Nakajo; P H Tu; T Tomita; K Nakaya; V M Lee; J Q Trojanowski; T Iwatsubo
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

8.  The structure and interactions of human apolipoprotein C-II in dodecyl phosphocholine.

Authors:  Christopher A MacRaild; Geoffrey J Howlett; Paul R Gooley
Journal:  Biochemistry       Date:  2004-06-29       Impact factor: 3.162

9.  Phosphorylation dependence of hsp27 multimeric size and molecular chaperone function.

Authors:  David Hayes; Vanessa Napoli; Andrew Mazurkie; Walter F Stafford; Philip Graceffa
Journal:  J Biol Chem       Date:  2009-04-30       Impact factor: 5.157

10.  Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis.

Authors:  Sadichhya Lohani; Emily Schuiteman; Lohit Garg; Dhiraj Yadav; Sami Zarouk
Journal:  Case Rep Nephrol       Date:  2016-10-20
View more
  10 in total

Review 1.  Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.

Authors:  Gouri Chopra; Shabnam Shabir; Sumaira Yousuf; Simran Kauts; Shahnawaz A Bhat; Ashiq H Mir; Mahendra P Singh
Journal:  Mol Neurobiol       Date:  2022-10-07       Impact factor: 5.682

2.  O-GlcNAc modification of small heat shock proteins enhances their anti-amyloid chaperone activity.

Authors:  Aaron T Balana; Paul M Levine; Timothy W Craven; Somnath Mukherjee; Nichole J Pedowitz; Stuart P Moon; Terry T Takahashi; Christian F W Becker; David Baker; Matthew R Pratt
Journal:  Nat Chem       Date:  2021-03-15       Impact factor: 24.427

Review 3.  Regulation by Different Types of Chaperones of Amyloid Transformation of Proteins Involved in the Development of Neurodegenerative Diseases.

Authors:  Vladimir I Muronetz; Sofia S Kudryavtseva; Evgeniia V Leisi; Lidia P Kurochkina; Kseniya V Barinova; Elena V Schmalhausen
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

4.  Exercise suppresses mouse systemic AApoAII amyloidosis through enhancement of the p38 MAPK signaling pathway.

Authors:  Xiaoran Cui; Jinko Sawashita; Jian Dai; Chang Liu; Yuichi Igarashi; Masayuki Mori; Hiroki Miyahara; Keiichi Higuchi
Journal:  Dis Model Mech       Date:  2022-03-21       Impact factor: 5.758

Review 5.  Insights Into the Role of Heat Shock Protein 27 in the Development of Neurodegeneration.

Authors:  Bianka A Holguin; Zacariah L Hildenbrand; Ricardo A Bernal
Journal:  Front Mol Neurosci       Date:  2022-03-30       Impact factor: 5.639

6.  Human HspB1, HspB3, HspB5 and HspB8: Shaping these disease factors during vertebrate evolution.

Authors:  Rainer Benndorf; Ryan Velazquez; Jordan D Zehr; Sergei L Kosakovsky Pond; Jody L Martin; Alexander G Lucaci
Journal:  Cell Stress Chaperones       Date:  2022-06-09       Impact factor: 3.827

Review 7.  The role and therapeutic potential of Hsp90, Hsp70, and smaller heat shock proteins in peripheral and central neuropathies.

Authors:  Subhabrata Chaudhury; Bradley M Keegan; Brian S J Blagg
Journal:  Med Res Rev       Date:  2020-08-25       Impact factor: 12.944

8.  Trends in HSPB5 research: a 36-year bibliometric analysis.

Authors:  Zhengdong Xu; Yehong Gong; Jiaqian Wan; Jiaxing Tang; Qingwen Zhang
Journal:  Cell Stress Chaperones       Date:  2021-07-07       Impact factor: 3.667

Review 9.  Secreted Chaperones in Neurodegeneration.

Authors:  Kriti Chaplot; Timothy S Jarvela; Iris Lindberg
Journal:  Front Aging Neurosci       Date:  2020-08-27       Impact factor: 5.750

Review 10.  Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease?

Authors:  Javier Navarro-Zaragoza; Lorena Cuenca-Bermejo; Pilar Almela; María-Luisa Laorden; María-Trinidad Herrero
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.